Literature DB >> 10189231

Antibacterial effect of some 2,6-disubstituted 4-anilinoquinazolines.

R Gottasová1, J Kubíková, L Cipák.   

Abstract

Two synthetic 2,6-disubstituted 4-anilinoquinazolines exerted a significant effect on the G+ bacteria Bacillus subtilis and staphylococcus aureus. None of 12 tested derivatives influenced Escherichia coli, Proteus mirabilis and Pseudomonas aeruginosa. Derivatives having the aromatic ring non-substituted or substituted by bromine, the pyrimidine ring by phenyl, morpholine or piperidine and the aniline skeleton non-substituted or substituted by methyl or amino group exerted a considerable antibacterial activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10189231     DOI: 10.1007/bf02816389

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  12 in total

1.  Synthesis of 3-aryl-2-substituted-4(3H)-quinazolines as potential antimicrobial agents.

Authors:  A M Farghaly; A Mohsen; M E Omar; M A Khalil; M A Gaber
Journal:  Farmaco       Date:  1990-04

2.  Non-steroidal antiinflammatory agents. Synthesis of novel 2-pyrazolyl-4(3H)-quinazolinones.

Authors:  A M Farghaly; I Chaaban; M A Khalil; A A Bekhit
Journal:  Arch Pharm (Weinheim)       Date:  1990-10       Impact factor: 3.751

Review 3.  Folate-based thymidylate synthase inhibitors in cancer chemotherapy.

Authors:  Y Takemura; A L Jackman
Journal:  Anticancer Drugs       Date:  1997-01       Impact factor: 2.248

4.  Antibacterial effect of substituted 4-quinazolyl-hydrazines and their arylhydrazones determined by a modified microdilution method.

Authors:  S Jantová; D Hudecová; S Stankovský; K Spirková; L Ruzeková
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Structure-activity relationships for 4-anilinoquinazolines as potent inhibitors at the ATP binding site of the epidermal growth factor receptor in vitro.

Authors:  W A Denny; G W Rewcastle; A J Bridges; D W Fry; A J Kraker
Journal:  Clin Exp Pharmacol Physiol       Date:  1996-05       Impact factor: 2.557

6.  Relationships between the structure, cytotoxicity and hydrophobicity of quinazoline derivatives by quantitative structure-activity relationship.

Authors:  S Jantová; S Baláz; S Stankovský; K Spirková; V Lukácová
Journal:  Folia Biol (Praha)       Date:  1997       Impact factor: 0.906

7.  Antimicrobial effects of the macrocyclic Cu(II)-tetraanhydroaminobenzaldehyde complex.

Authors:  S Jantová; J Labuda; V Vollek; M Zastková
Journal:  Folia Microbiol (Praha)       Date:  1997       Impact factor: 2.099

8.  Synthesis and antibacterial activity of certain quinoline and quinazoline derivatives containing sulfide and sulfone moieties.

Authors:  M F el-Zohry; A A Ahmed; F A Omar; M A Abd-Alla
Journal:  J Chem Technol Biotechnol       Date:  1992       Impact factor: 3.174

9.  Synthesis and anticonvulsant activity of new acylthiosemicarbazides and thiazolidones.

Authors:  A Gürsoy; N Karali
Journal:  Farmaco       Date:  1995-12

10.  3-(1H-tetrazol-5-yl)-4(3H)-quinazolinone sodium salt (MDL 427): a new antiallergic agent.

Authors:  N P Peet; L E Baugh; S Sunder; J E Lewis; E H Matthews; E L Olberding; D N Shah
Journal:  J Med Chem       Date:  1986-11       Impact factor: 7.446

View more
  3 in total

1.  Antibacterial effect of some substituted tricyclic quinazolines and their synthetic precursors.

Authors:  S Jantová; K Spirková; S Stankovský; P Duchonová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.099

2.  Selective medium for primary isolation of members of the tribe Proteeae.

Authors:  E Urbanová
Journal:  Folia Microbiol (Praha)       Date:  1999       Impact factor: 2.629

3.  Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives.

Authors:  Rezvan Rezaee Nasab; Farshid Hassanzadeh; Ghadam Ali Khodarahmi; Mahboubeh Rostami; Mahmoud Mirzaei; Ali Jahanian-Najafabadi; Mahboubeh Mansourian
Journal:  Res Pharm Sci       Date:  2017-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.